Nicholas Wood, Associate Professor, Discipline of Childhood and Adolescent Health, the University of Sydney. The Conversation, August 25th, 2021.
In July Australia’s Therapeutic Goods Administration (TGA) provisionally approved the Pfizer COVID-19 vaccine for kids aged 12-15.
The Australian Technical Advisory group on Immunisation (ATAGI) subsequently recommended kids in this age group with underlying chronic medical conditions, Aboriginal and Torres Strait Islander children and kids living in remote communities should be prioritised.
We’re expecting advice from ATAGI as to whether the rollout should be extended to all 12 to 15-year-olds, as countries like the United States and Canada have done. But where does that leave children under 12?
Click here to read the full article.